TG Therapeutics Reports Strong Revenue, Shares Surge Despite Market Decline
TG Therapeutics shares surged 11.6% to $31.10 following the announcement of a preliminary total global revenue of approximately $616 million for FY 2025, with Q4 U.S. net product revenue for BRIUMVI at about $182 million.
The strong financial performance, despite a broader market decline with the Nasdaq Composite falling over 200 points, showcases TG Therapeutics' competitiveness in the biopharmaceutical sector. The preliminary results suggest that the company is poised for continued growth, particularly in the marketing of its BRIUMVI product, which could further enhance its market share.
This optimistic outlook is expected to boost shareholder confidence and attract more capital inflow, positioning TG Therapeutics favorably in a challenging market environment.
Trade with 70% Backtested Accuracy
Analyst Views on ADNT
About ADNT
About the author

- Material Innovation: Adient has launched Sculpted Soft Trim, a new soft trim solution that reduces sewing requirements through automation, significantly enhancing the aesthetics and flexibility of seat designs, which is expected to redefine standards in the automotive seating market.
- Efficiency Gains: The forming cycle for this material is reduced to 50% of traditional methods, not only increasing production speed but also ensuring consistent high-end craftsmanship, helping OEMs maintain a competitive edge in a challenging market.
- Increased Design Freedom: Sculpted Soft Trim can replace up to 12 traditional sewing patterns, simplifying complex seat designs, particularly in challenging areas like child seat anchor points, thereby elevating craftsmanship and design possibilities.
- Global Market Deployment: The material is now available globally and will be in production in multiple OEM vehicles, marking Adient's ongoing innovation and market expansion in the automotive seating sector.
- Material Innovation: Adient's Sculpted Soft Trim is a soft, breathable trim solution that allows for the creation of larger or more intricate trim panels, significantly enhancing the aesthetic and design freedom of automotive seating.
- Efficiency Gains: The material utilizes an automated process that reduces the sewing required compared to traditional trim covers, cutting production cycle times to roughly 50% of conventional methods, thereby improving manufacturing efficiency and product quality.
- Complexity Reduction: Sculpted Soft Trim can replace up to twelve individual patterns traditionally needed for components like child seat anchor locations, simplifying production and enhancing craftsmanship while reducing labor costs.
- Global Market Deployment: This innovative material is now available globally and will be in production on seats for multiple OEM vehicles this year, reinforcing Adient's leadership position in the automotive seating market.
- Goldman Sachs Reiterates Nvidia: Goldman Sachs maintains a Buy rating on Nvidia ahead of its earnings report, expecting investors to focus on visibility into 2027, non-traditional customer demand, and trends in the Chinese market, indicating strong market confidence in Nvidia's future growth.
- Benchmark Initiates Cava Rating: Benchmark initiates coverage of CAVA Group with a Buy rating and an $80 price target, reflecting its leadership position in the rapidly emerging Mediterranean dining market, which is expected to attract more investor interest in this burgeoning sector.
- BMO Capital Upgrades Brookfield: BMO upgrades Brookfield Asset Management from Market Perform to Outperform, citing attractive mid-teens distributable earnings growth prospects underpinned by continued fundraising momentum and fee rate resilience, showcasing the company's robust financial health.
- Bank of America Downgrades Qualcomm: Bank of America downgrades Qualcomm from Buy to Neutral, lowering the price target from $215 to $155 due to concerns over cyclical and structural weaknesses in the handset market, which may adversely affect its future performance.

- Revenue Growth: Adient plc reported $3.6 billion in revenue for Q1 2026, marking a 4% year-over-year increase primarily driven by favorable FX impacts from Europe and significant growth in China, effectively offsetting production challenges in North America and demonstrating the company's resilience in global markets.
- Adjusted EBITDA Performance: The adjusted EBITDA for the first quarter stood at $207 million, reflecting a 6% increase compared to the same period last year, with an EBITDA margin of 5.7%, indicating ongoing improvements in cost control and operational efficiency, which bolster confidence in future profitability.
- Shareholder Returns and Liquidity: The company repurchased $25 million in shares during the quarter, ending with a cash balance of $855 million and total liquidity of $1.7 billion, showcasing strong financial health and commitment to shareholders, which is expected to support future investments and growth.
- Outlook Enhancement: Adient raised its full-year 2026 sales guidance to approximately $14.6 billion, with adjusted EBITDA expectations of around $880 million and free cash flow of $125 million, reflecting the company's confidence in future growth, particularly through investments in automation and onshoring opportunities that will drive business performance.
- Earnings Beat: Adient's Q1 FY2026 non-GAAP EPS of $0.35 exceeded expectations by $0.16, indicating a significant improvement in the company's profitability.
- Revenue Growth: The company reported Q1 revenue of $3.64 billion, a 4.3% year-over-year increase that surpassed market expectations by $160 million, reflecting strong performance amid automotive industry recovery.
- Adjusted EBITDA Improvement: Q1 adjusted EBITDA reached $207 million, an $11 million year-over-year improvement, with adjusted EBITDA margins increasing from 5.6% to 5.7%, showcasing advancements in cost control and operational efficiency.
- Shareholder Returns and Upgraded Outlook: Adient repurchased approximately 1.2 million shares for $25 million in Q1 while raising FY26 revenue and free cash flow guidance to $14.6 billion and $125 million, respectively, reflecting optimism about future business performance.







